Health Law Diagnosis – DEA Extends Pandemic Telehealth Prescribing Flexibilities For Up To 18 Months

Start
On May 9, 2023, the Drug Enforcement Administration (DEA) issued a temporary rule that extends pandemic-era flexibilities allowing prescribing of controlled substances based on a telehealth relationship, after receiving in excess of 38,000 comments on its March 1, 2023, proposed rules (previously discussed) to extend certain of those flexibilities but allow others to end upon expiration of the COVID-19 public health emergency on May 11, 2023. The Temporary Rule provides the DEA with additional…
By: Robinson & Cole LLP
Previous Story

Amtel, LLC dba Connectivity Source Notifies 17,835 Current and Former Employees of Recent Data Breach

Next Story

Proposed Regulatory Oversight on the Emerging Use of Artificial Intelligence in Digital Health